Online citations, reference lists, and bibliographies.
← Back to Search

Malignant Pleural Mesothelioma: Clinicopathologic And Survival Characteristic In A Consecutive Series Of 40 Patients.

R. Bagheri, S. Z. Haghi, M. B. Rahim, Davoud Attaran, M. Toosi
Published 2011 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
INTRODUCTION Pleural malignant mesothelioma is an uncommon but extremely invasive tumor which originates from mesothelial cells and usually occurs after prolonged exposure to asbestos. Different types of surgical and oncological therapeutic methods have been used resulting in various outcomes. The aim of this study was to evaluate, clinicopathologically, 40 patients with pleural malignant mesothelioma and the main factors influencing their prognosis. METHODS In this study, 40 patients with a definitive diagnosis, who had been followed up for at least 3 years were studied according to these: epidemiologic factors, stage and pathological types, treatment method and complications, and by using factors that influence patients survival, we evaluated them statistically. RESULTS The M/F ratio was l3/1 with an average age of 55 years. Chest pain was the most common symptom. In 55% of patients, the lesions were localized in the left site and most were in Buchart stage I or II. The epithelial form was the most common pathological pattern (62.5%). 47.5% of patients only received radiotherapy and chemotherapy. Of patients who underwent decortication and pleurectomy with adjuvant therapy, extrapleural was performed in 20% of patients, and pneumonectomy, in 17.5%; and 15% refused any type of treatment. One patient died from the surgery. The most common surgical complication was wound infection. The average survival was 10.5 months, and the main factors influencing the survival were physiologic status, pathological form of disease, stage of disease and the pattern of pleural involvement. CONCLUSION Because of the low survival after multimodality invasive treatments in mesothelioma, aggressive therapeutic methods were recommended in patients with good physiological status and early clinical stage with a good pathology type.
This paper references
10.1510/ICVTS.2007.166322
Radical surgery for malignant pleural mesothelioma: results and prognosis.
M. Okada (2008)
10.1007/s12199-007-0017-6
Pathology of mesothelioma
K. Inai (2008)
[Prognosis, staging and therapy of malignant pleural mesothelioma].
W. Neumeister (2002)
Epidemiology of Mesothelioma
N. Klerk (2002)
10.1136/thx.31.1.15
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
E. Butchart (1976)
10.1080/01913120252959227
Malignant Mesothelioma and Occupational Exposure to Asbestos: A Clinicopathological Correlation of 1445 Cases
V. Roggli (2002)
10.1016/j.athoracsur.2008.01.088
The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma.
T. Mineo (2008)
10.1016/j.jtcvs.2007.10.054
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
R. Flores (2008)
10.1002/JSO.2930600207
Optimal management of malignant mesothelioma after subtotal pleurectomy: Revisiting the role of intrapleural chemotherapy and postoperative radiation
E. Sauter (1995)
10.1080/14774003.2005.11667666
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
Tim J. Carter (2005)
Pathology of mesothelioma, In: Robinson BWS, Chahinian AP, eds, Mesothelioma
A Segal (2002)
Simian virus 40-like DNA sequences in human pleural mesothelioma.
M. Carbone (1994)
10.1016/S0022-5223(19)36578-X
Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.
D. Sugarbaker (1991)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1016/S1569-9293(02)00093-2
Malignant pleural mesothelioma: outcome of limited surgical management.
P. G. Phillips (2003)
10.1016/S1077-9108(08)79041-8
Malignant Pleural Mesothelioma: Surgical Management in 285 Patients
P. Bejarano (2009)
Malignant mesothelioma: A ten years experience
C Lopes (2005)
10.1016/J.EJCTS.2007.01.064
Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.
A. Martin-Ucar (2007)
10.1016/J.EJCTS.2006.11.046
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
M. Lucchi (2007)
10.1002/DC.20208
The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: A comparative study
R. Saad (2005)
10.1111/j.1440-1843.2004.00599.x
Radiology in pleural disease: State of the art
A. L. Evans (2004)
Systemic drug therapy of malignant pleural mesothelioma.
A. Ardizzoni (1998)
10.1007/978-1-4615-1589-0_13
Malignant pleural mesothelioma.
L. Ho (2001)
10.1093/OCCMED/33.4.190
The epidemiology of mesothelioma.
K. Browne (1983)
10.1111/j.1440-1843.2005.00763.x
Prolonged survival after talc poudrage for malignant pleural mesothelioma: Case series
Y. Aelony (2005)
10.1016/j.ejcts.2008.03.003
Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
C. Aigner (2008)
10.1016/j.ejcts.2008.03.034
Video-assisted cervical thoracoscopy: a novel approach for diagnosis, staging and pleurodesis of malignant pleural mesothelioma.
M. Chamberlain (2008)
10.1097/00063198-200007000-00003
Management of malignant pleural mesothelioma: a critical review
Y. Lee (2000)
10.1055/S-2007-1013677
Videothoracoscopy in the diagnosis and treatment of malignant pleural mesothelioma with associated pleural effusions.
A. Cantó (1997)



This paper is referenced by
Clinicopathologic and Survival Characteristics of Malignant Pleural Mesothelioma Registered in Hospital Cancer Registry
K. Najmi (2014)
10.4236/HEALTH.2013.56129
Mesothelioma in relation to asbestos exposure in laboratory work
P. Sripaiboonkij (2013)
10.1136/bcr-2013-009850
Unusual presentation and location pleural malignant mesothelioma
A. Kumar (2013)
10.4132/KoreanJPathol.2014.48.2.91
Pleural Mesothelioma: An Institutional Experience of 66 Cases
Soomin Ahn (2014)
10.17877/DE290R-6925
Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma
LV Gayosso-Gómez (2014)
10.1016/j.yexmp.2014.09.016
Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets.
E. G. Ramírez-Salazar (2014)
10.21608/EJOM.2019.31415
ENVIRONMENTAL AND OCCUPATIONAL RISK FACTORS AND PREDICTORS OF SURVIVAL AMONG MALIGNANT PLEURAL MESOTHELIOMA PATIENTS
A. Abdel-HamidM (2019)
Wczesne i odległe wyniki leczenia złośliwego międzybłoniaka opłucnej na podstawie analizy 170 przypadków
Bryl Maciej (2012)
10.1093/icvts/ivt365
Localized mesothelioma tumour arising synchronously with a primary contralateral lung cancer.
Weston G Andrews (2013)
10.2147/OTT.S36915
Pegylated liposomal doxorubicin in malignant pleural mesothelioma: a possible guardian for long-term survival
P. Zarogoulidis (2012)
10.1007/978-3-030-40679-0_42
Intraoperative Accidents and Postoperative Complications in the Surgery of Pleural Tumours
M. Vayvada (2020)
10.2427/10106
Kandovan the next 'Capadoccia'? A potential public health issue for erionite related mesothelioma risk
E. B. Ilgren (2015)
10.1007/s00432-013-1523-0
Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma
Zhou-Hong Yao (2013)
10.1510/icvts.2008.195685
The role of thoracoscopy for the diagnosis of hidden diaphragmatic injuries in penetrating thoracoabdominal trauma.
R. Bagheri (2009)
10.12816/EJHM.2019.28870
Role of Multislice CT in Diagnosis, Staging and Evaluation of Malignant Pleural Mesothelioma
Dina Ahmed Hassan Torky (2019)
10.30699/IJP.14.2.122
The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion
Monireh Halimi (2019)
10.3748/wjg.v20.i30.10537
Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer.
N. Jiang (2014)
10.1016/B978-1-4557-2532-8.00021-9
21 – Lung Cancer: Clinical Aspects
S. Weinberger (2014)
Semantic Scholar Logo Some data provided by SemanticScholar